Basing empiric treatment choices for respiratory tract infection on the results of the Alexander Project

Journal of Chemotherapy

Volumn 11, Issue SUPPL. 1, 1999, Pages 51-55

  Garau, J ^a  

^a HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

Guidelines; Pneumonia; Respiratory tract infection; Surveillance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFOTAXIME; CEFPIROME; CHLORAMPHENICOL; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL PNEUMONIA; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG CHOICE; DRUG COST; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; MEDICAL DECISION MAKING; MORAXELLA CATARRHALIS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032957481     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1999.11.supplement-2.51     Document Type: Conference Paper

References (22)

1. Hosker HSR, Jones GM, Hawkey P. Management of community acquired lower respiratory tract infection. Br Med J 1994; 308: 701-705.
2. Legnani D. Role of oral antibiotics in treatment of community-acquired lower respiratory tract infections. Diagn Microbiol Infect Dis 1997; 27: 41-47.
3. Vogel F. A guide to the treatment of lower respiratory tract infections. Drugs 1995; 50: 62-72.
4. Felmingham D. Antibiotic resistance. Do we need new therapeutic approaches? Chest 1995; 108 (Suppl 2): 70S-78S.
5. Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: a continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169-181.
6. Goldstein FW, Garau J. Resistant pneumococci: a renewed threat in respiratory infections. Scand J Infect Dis Suppl 1994; 93: 55-62.
7. Linares, Alonso T, Ayats J, et al. In vitro activity of seven macrolide antibiotics and nine other antimicrobial agents against penicillin-resistant pneumococci. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, USA 1991: Abstract 191.
8. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-12.
9. Gavaldá J, Capdevila JA, Almirante B, Otero J, Ruiz I, Laguarda M, Allende H, Crespo E, Pigrau C, Pahissa A. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats. Antimicrob Agents Chemother 1997; 41: 795-801.
10. Sanchez C, Armengol R, Lite J, Mir I, Garau J. Penicillin-resistant pneumococci and community-acquired pneumonia. Lancet 1992; 339(8799): 988.
11. Dorca J, Esteban L, Alonso T, Barreito B Verdaguer R, Manresa F. Rapid diagnosis of pneumococcal pneumonia by latex agglutination and CIE in samples obtained by transthoracic needle aspiration. Am Rev Respir Dis 1993; 147: A653.
12. American Thoracic Society. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-1426.
13. Bartlett JG, Breiman RF, Mandell LA, Filet TM. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis 1998; 26: 811-838
14. Evans GM, Gainsford WF. Treatment of pneumonia with 2-(p-aminobenzenesulphonamido) pyridine. Lancet 1938; 2: 14-19.
15. Guimard J, Correze JR, Choutet P. Les trois références médicales opposables en pathologie infectieuse. La Revue du Praticien 1998; 12: 17-20.
16. Garau J. Clinical perspectives of the management of community-acquired pneumonia. Diagn Microbiol Infect Dis 1996; 25: 205-211.
17. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN. A prediction rule to identify low-risk patients with community-acquired pneumonia. NEJM 1997; 336: 243-250.
18. Carbon C, Leophonte P. Management of community-acquired pneumonia. J Antimicrob Chemother 1993; 32: 1-3.
19. Eron JJ, Burkle W, Cohen MS. Managing pneumonia: defining the role of the new macrolide antibiotics. Hosp Formul 1994 ;29: 136
20. Jones RN. Can antimicrobial therapy be sustained? An appraisal of orally administered drugs used for respiratory tract infections. Diagn Microbiol Infect Dis 1997; 27: 21-29.
21. Pallares R, Linares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333(8): 474-480. (Published erratum appears in N Engl J Med 1995; 333(24): 1655)
22. th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego CA, USA 1998: Abstract L-107.